CFDE Data Portal | Search EGFLAM-AS5

	Label	Description
	EGFLAM-AS5 Gene (Entity type)	ENSG00000251257 - EGFLAM antisense RNA 5
	GSE199107 tryptophan 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE60217 adenosine 1 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE161800 cisplatin A-549 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

EGFLAM-AS5

ENSG00000251257 - EGFLAM antisense RNA 5

GSE199107 tryptophan 6 v 7 human up

A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 7 human up

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 3 human up

A Gene Set from LINCS

GSE60217 adenosine 1 v 7 human up

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 5 human dn

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn

A Gene Set from LINCS

GSE161800 cisplatin A-549 0 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.